Track BlackRock Mid-Cap Growth Equity Portfolio's common stock ($130M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
The latest common stock for BMRRX is $130M as of March 2025. That compares with $110M in the prior-year period — up 15.9% year over year. Investors often review this figure alongside BlackRock Mid-Cap Growth Equity Portfolio's historical trend and sector peers before judging valuation or financial health.
Over the past year, BMRRX's common stock moved from $110M to $130M — a 15.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BlackRock Mid-Cap Growth Equity Portfolio's operating scale or balance-sheet position.
A common stock figure of $130M for BMRRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting BMRRX's common stock ($130M), review year-over-year change from $110M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.